(Total Views: 1142)
Posted On: 09/10/2020 6:13:24 PM
Post# of 155727
I don't understand why people expect immediate news to come out after meetings with the FDA and the UK authorities, especially if you are an investor in the stock as opposed to a day trader.
If you believe in the stock then you will wait it out for the conference calls next week. Most public companies would not even be having as many conference calls and keeping investors informed on every little movement in the company. When they were ready they would issue a press release. You would normally have to wait for conference calls with the company after quarterly earnings.
I hope that once they are listed on the NASDAQ that this approach will be followed.
6 days wait is not an eternity. If you think there will be bad news, now is the opportunity to exit. For those that are investors you will wait it out because this company has many, many irons in the fire.
Looking forward to some valuable information being provided next week. At least obtaining a PDUFA date for HIV. It would also be great if the UK wanted to move forward with us and gave us $25-50 million to move forward with leronlimab for Covid in the U.K.
If you believe in the stock then you will wait it out for the conference calls next week. Most public companies would not even be having as many conference calls and keeping investors informed on every little movement in the company. When they were ready they would issue a press release. You would normally have to wait for conference calls with the company after quarterly earnings.
I hope that once they are listed on the NASDAQ that this approach will be followed.
6 days wait is not an eternity. If you think there will be bad news, now is the opportunity to exit. For those that are investors you will wait it out because this company has many, many irons in the fire.
Looking forward to some valuable information being provided next week. At least obtaining a PDUFA date for HIV. It would also be great if the UK wanted to move forward with us and gave us $25-50 million to move forward with leronlimab for Covid in the U.K.
(8)
(0)
